December 28, 2011 /

Biglycan (December 2011)

by: Parent Project Muscular Dystrophy

Biglycan (December 2011)

Biglycan as a protein therapeutic for Duchenne Muscular Dystrophy Justin R. Fallon, Department of Neuroscience, Brown University

14 years ago

Research & Clinical Trial Webinars,

You may also like

Webinar: Advancing DYNE-251 - An Investigational Medicine for Duchenne to Deliver for Patients

Webinar: Advancing DYNE-251 – An Investigational Medicine for Duchenne to Deliver for Patients

1 year ago

Research & Clinical Trial Webinars,

dyne therapeutics,

Webinar: Edgewise Therapeutics - Clinical Trials in Becker Muscular Dystrophy

Webinar: Edgewise Therapeutics – Clinical Trials in Becker Muscular Dystrophy

2 years ago

Research & Clinical Trial Webinars,

Webinar: Community Progress in Duchenne Newborn Screening

Webinar: Community Progress in Duchenne Newborn Screening

2 years ago

newborn screening

Webinar: Community Update with ITF Therapeutics – Introducing DUVYZAT™ (givinostat)

Webinar: Community Update with ITF Therapeutics – Introducing DUVYZAT™ (givinostat)

2 years ago

Research & Clinical Trial Webinars,

itf therapeutics

Webinar: Sarepta Therapeutics - Data update from MOMENTUM study, SRP-5051

Webinar: Sarepta Therapeutics – Data update from MOMENTUM study, SRP-5051

2 years ago

Research & Clinical Trial Webinars,

Webinar: NS Pharma - Overview of New Exon Skipping Trials: Brogidirsen and NS-050/NCNP-03

Webinar: NS Pharma – Overview of New Exon Skipping Trials: Brogidirsen and NS-050/NCNP-03

2 years ago

Research & Clinical Trial Webinars,

Overview of WVE-N531 and the FORWARD-53 Clinical Trial with Wave Life Sciences

Overview of WVE-N531 and the FORWARD-53 Clinical Trial with Wave Life Sciences

2 years ago

Research & Clinical Trial Webinars,

wave life sciences,

PTC Therapeutics — EMFLAZA® Landscape in 2024

PTC Therapeutics — EMFLAZA® Landscape in 2024

2 years ago

ptc therapeutics

«1…3 456 7…28 »

Page 5 of 28

Join Our Mailing List